AbbVie Income from Continuous Operations 2010-2024 | ABBV

AbbVie income from continuous operations for the twelve months ending December 31, 2024 was $4.286B, a 12.05% decline year-over-year.

  • AbbVie annual income from continuous operations for 2024 was $4.286B, a 12.05% decline from 2023.
  • AbbVie annual income from continuous operations for 2023 was $4.873B, a 58.86% decline from 2022.
  • AbbVie annual income from continuous operations for 2022 was $11.845B, a 2.56% increase from 2021.

AbbVie Income from Continuous Operations 2010-2024 | ABBV

  • AbbVie annual income from continuous operations for 2024 was $4.286B, a 12.05% decline from 2023.
  • AbbVie annual income from continuous operations for 2023 was $4.873B, a 58.86% decline from 2022.
  • AbbVie annual income from continuous operations for 2022 was $11.845B, a 2.56% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B